Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Total Non-Current Liabilities: 2016-2025

Historic Total Non-Current Liabilities for Collegium Pharmaceutical (COLL) over the last 4 years, with Sep 2025 value amounting to $1.3 billion.

  • Collegium Pharmaceutical's Total Non-Current Liabilities fell 4.60% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 4.60%. This contributed to the annual value of $1.4 billion for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Collegium Pharmaceutical's Total Non-Current Liabilities is $1.3 billion, which was down 2.05% from $1.4 billion recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Total Non-Current Liabilities registered a high of $1.4 billion during Q4 2024, and its lowest value of $1.3 billion during Q3 2025.
  • In the last 2 years, Collegium Pharmaceutical's Total Non-Current Liabilities had a median value of $1.4 billion in 2025 and averaged $1.4 billion.
  • Data for Collegium Pharmaceutical's Total Non-Current Liabilities shows a maximum YoY fell of 4.60% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Collegium Pharmaceutical's Total Non-Current Liabilities stood at $1.4 billion in 2024, then declined by 4.60% to $1.3 billion in 2025.
  • Its Total Non-Current Liabilities stands at $1.3 billion for Q3 2025, versus $1.4 billion for Q2 2025 and $1.4 billion for Q1 2025.